Mdm2 promotes the rapid degradation of p53

Haupt, Ygal, Maya, Ruth, Kazaz, Anat, Oren, Moshe·1997·Nature
DOI 10.1038/387296a0

Cited by (1,057)

Items 401–500 of 1,057

  1. Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1
    Hye‐Kyung Na, Young‐Joon Surh · 2013 · Free Radical Biology and Medicine
  2. p53 regulation of ammonia metabolism through urea cycle controls polyamine biosynthesis
    Le Li, Youxiang Mao, Lina Zhao, Lijia Li, Jinjun Wu, Mengjia Zhao, Wenjing Du, Yu Li, Peng Jiang · 2019 · Nature
  3. The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity
    Poyurovsky, Masha V, Priest, Christina, Kentsis, Alex, Borden, Katherine LB, Pan, Zhen‐Qiang, Pavletich, Nikola, Prives, Carol · 2007 · The EMBO Journal
  4. p53 Signaling and Cell Cycle Checkpoints
    Zoe A. Stewart, Jennifer A. Pietenpol · 2001 · Chemical Research in Toxicology
  5. MDM2 Acts Downstream of p53 as an E3 Ligase to Promote FOXO Ubiquitination and Degradation
    Wei Fu, Qiuping Ma, Lei Chen, Pengfei Li, Mu Zhang, Sivapriya Ramamoorthy, Zafar Nawaz, Tsukasa Shimojima, Hengbin Wang, Yonghua Yang et al. · 2009 · Journal of Biological Chemistry
  6. New therapeutic strategies to treat human cancers expressing mutant p53 proteins
    Giovanni Blandino, Silvia Di Agostino · 2018 · Journal of Experimental & Clinical Cancer Research
  7. 5-Fluorouracil Activation of p53 Involves an MDM2-Ribosomal Protein Interaction
    Xiao‐Xin Sun, Mu‐Shui Dai, Hua Lu · 2007 · Journal of Biological Chemistry
  8. Tyrosine phosphorylation of Mdm2 by c‐Abl: implications for p53 regulation
    Zehavit Goldberg, Ronit Vogt Sionov, Michael Berger, Yaara Zwang, Ruth Perets, Richard A. Van Etten, Moshe Oren, Yoichi Taya, Ygal Haupt · 2002 · The EMBO Journal
  9. Differential Transactivation by the p53 Transcription Factor Is Highly Dependent on p53 Level and Promoter Target Sequence
    Alberto Inga, Francesca Storici, Thomas A. Darden, Michael A. Resnick · 2002 · Molecular and Cellular Biology
  10. Cancer Risk and the ATM Gene: a Continuing Debate
    Kum Kum Khanna · 2000 · JNCI Journal of the National Cancer Institute
  11. Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment
    Wen Li, Feifei Li, Xia Zhang, Hui‐Kuan Lin, Chuan Shan Xu · 2021 · Signal Transduction and Targeted Therapy
  12. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen‐activated protein kinase and JAK/STAT pathways
    Patrick B. Arbuthnot, Alexio Capovilla, Michael Charles Kew · 2000 · Journal of Gastroenterology and Hepatology
  13. Mutual interactions between the SUMO and ubiquitin systems: a plea of no contest
    Helle D. Ulrich · 2005 · Trends in Cell Biology
  14. Cellular UV damage responses—Functions of tumor suppressor p53
    Leena Latonen, Marikki Laiho · 2005 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  15. Mutant p53: it’s not all one and the same
    Margaret C. Kennedy, Scott W. Lowe · 2022 · Cell Death and Differentiation
  16. Signaling angiogenesis via p42/p44 MAP kinase and hypoxia
    Edurne Berra, Julie Milanini, Darren E. Richard, Maude Le Gall, Francesc Viñals, Emmanuel Gothié, Danièle Roux, Gilles Pagès, Jacques Pouysségur · 2000 · Biochemical Pharmacology
  17. A transactivation-deficient mouse model provides insights into Trp53 regulation and function
    Gretchen S. Jimenez, Monica Nistér, Jayne M. Stommel, Michelle Beeche, Erin A. Barcarse, Xiao-Qun Zhang, Stephen O’Gorman, Geoffrey M. Wahl · 2000 · Nature Genetics
  18. Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1
    Xiao‐Xin Sun, Kishore B. Challagundla, Mu‐Shui Dai · 2011 · The EMBO Journal
  19. Alternative and aberrant splicing of MDM2 mRNA in human cancer
    Frank Bartel, Helge W. Taubert, Linda C. Harris · 2002 · Cancer Cell
  20. High level expression of ΔN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?
    Tim Crook, John Malcolm Nicholls, Louise A. Brooks, Jenny O’Nions, Martin J. Allday · 2000 · Oncogene
  21. Topors Functions as an E3 Ubiquitin Ligase with Specific E2 Enzymes and Ubiquitinates p53
    Rajeev Rajendra, Diptee Malegaonkar, Pooja Pungaliya, Henderson Marshall, Zeshaan A. Rasheed, James E. Brownell, Leroy F. Liu, Stuart G. Lutzker, Ahamed Saleem, Eric H. Rubin · 2004 · Journal of Biological Chemistry
  22. MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins
    Eric Kobet, Xiaoya Zeng, Yong Zhu, David Keller, Hua Lu · 2000 · Proceedings of the National Academy of Sciences
  23. Mdm2: The Ups and Downs
    Tamar Juven‐Gershon, Moshe Oren · 1999 · Molecular Medicine
  24. Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer
    Tohru Yamada, Masatoshi Goto, Vasu Punj, Olga E. Zaborina, Mei Ling Chen, Kazuhide Kimbara, Dibyen Majumdar, Elizabeth Ann Cunningham, Tapas K. Das Gupta, Ananda Mohan Chakrabarty · 2002 · Proceedings of the National Academy of Sciences
  25. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis
    Juan Antonio Bernal, Rosa Luna, Águeda G. Espina, Iciar Lazaro‐Trueba, Francisco Ramos‐Morales, Francisco Romero, Carmen Arias, Augusto Silva, Marı́a Tortolero, José A. Pintor‐Toro · 2002 · Nature Genetics
  26. Regulation of Mdm2-Directed Degradation by the C Terminus of p53
    Michael H.G. Kubbutat, Robert L. Ludwig, Margaret A. Ashcroft, Karen H. Vousden · 1998 · Molecular and Cellular Biology
  27. miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress
    Xiao, Jiening, Lin, Huixian, Luo, Xiaobin, Luo, Xiaoyan, Wang, Zhiguo · 2011 · The EMBO Journal
  28. mdmx is a negative regulator of p53 activity in vivo.
    Rick A. Finch, Dorit B. Donoviel, David Potter, Min Shi, Amy Fan, D D Freed, Ching-Yun Wang, Brian Zambrowicz, Ramiro Ramírez‐Solis, Arthur Sands et al. · 2002 · PubMed
  29. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity
    Tamar Unger, Ronit Vogt Sionov, Eli Moallem, Carole Yee, Peter M. Howley, Moshe Oren, Ygal Haupt · 1999 · Oncogene
  30. Loss of p53 and centrosome hyperamplification
    Pheruza Tarapore, Kenji Fukasawa · 2002 · Oncogene
  31. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2.
    T F Kowalik, James V. DeGregori, Gustavo W. Leone, Laszlo Jakoi, Joseph Roy Nevins · 1998 · PubMed
  32. Comparative study of the p53-mdm2 and p53-MDMX interfaces
    Böttger, Volker, Böttger, Angelika, Garcia-Echeverria, Carlos, Ramos, Yolande FM, van der Eb, Alex J, Jochemsen, Aart G, Lane, David P · 1999 · Oncogene
  33. Mdmx as an essential regulator of p53 activity
    Jean‐Christophe Marine, Aart G. Jochemsen · 2005 · Biochemical and Biophysical Research Communications
  34. UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
    Yoshiaki Okamoto, Toshinori Ozaki, Kou Miyazaki, Mineyoshi Aoyama, Masaru Miyazaki, Akira Nakagawara · 2003 · PubMed
  35. p53 regulation by ubiquitin
    Brooks, Christopher L., Gu, Wei · 2011 · FEBS Letters
  36. Targeting protein–protein interactions: Lessons from p53/MDM2
    Justin K. Murray, Samuel H. Gellman · 2007 · Biopolymers
  37. 20S proteasomes and protein degradation “by default”
    Gad Asher, Nina Bacher Reuven, Yosef Shaul · 2006 · BioEssays
  38. Deubiquitinating enzymes—the importance of driving in reverse along the ubiquitin–proteasome pathway
    Simon S. Wing · 2003 · The International Journal of Biochemistry & Cell Biology
  39. A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter
    Vanessa Brès, Rosemary Kiernan, Laetitia K. Linares, C. Chable-Bessia, Olga Plechakova, Céline Tréand, S. Emiliani, J. Peloponese, K. Jeang, O. Coux et al. · 2003 · Nature Cell Biology
  40. The p53 tumour suppressor gene
    Robert JC Steele, Alastair Mark Thompson, Peter A. Hall, David Philip Lane · 1998 · British journal of surgery
  41. Characterization of Structural p53 Mutants Which Show Selective Defects in Apoptosis but Not Cell Cycle Arrest
    Kevin M. Ryan, Karen H. Vousden · 1998 · Molecular and Cellular Biology
  42. p53 regulates Period2 expression and the circadian clock
    Takao Miki, Tomoko Matsumoto, Zhaoyang Zhao, Cheng Chi Lee · 2013 · Nature Communications
  43. Inhibition of MDM2 by hsp90 Contributes to Mutant p53 Stabilization
    Yanhua Peng, Lihong Chen, Changgong Li, Wenge Lu, Jiandong Chen · 2001 · Journal of Biological Chemistry
  44. Regulation of p53 stability and activity in response to genotoxic stress
    Michael S. Colman, Cynthia A. Afshari, J. Carl Barrett · 2000 · Mutation Research/Reviews in Mutation Research
  45. Quinone Reductases Multitasking in the Metabolic World
    David Ross · 2004 · Drug Metabolism Reviews
  46. Methylation Silencing and Mutations of the p14ARF and p16INK4a Genes in Colon Cancer
    Nathalie Hirt‐Burri, Phillip H. Shaw, Hanifa Bouzourène, Isabelle Sordat, Bernard Sordat, M Gillet, Daniel F. Schorderet, Fred T. Bosman, Pascal Chaubert · 2001 · Laboratory Investigation
  47. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells.
    Taija M. Kiviharju, Philip S. Lecane, Robert G. Sellers, Donna M. Peehl · 2002 · PubMed
  48. Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11
    Masato Sasaki, Kohichi Kawahara, Miki Nishio, Koshi Mimori, Ryunosuke Kogo, Koichi Hamada, Bunsho Itoh, Jia Wang, Yukako Komatsu, Yong Ryoul Yang et al. · 2011 · Nature Medicine
  49. Regulating the p53 system through ubiquitination
    Yili Yang, Chou-Chi H. Li, Allan M. Weissman · 2004 · Oncogene
  50. Cutaneous Photobiology. The Melanocyte vs. the Sun: Who Will Win the Final Round?
    Ana Luisa Kadekaro, Renny J. Kavanagh, Kazumasa Wakamatsu, Shosuke Ito, Michelle A. Pipitone, ZALFA A. ABDEL‐MALEK · 2003 · Pigment Cell Research
  51. Kinetics of p53 Binding to Promoter Sites In Vivo
    Suzanne T. Szak, Deborah J. Mays, Jennifer A. Pietenpol · 2001 · Molecular and Cellular Biology
  52. The Arabidopsis elch mutant reveals functions of an ESCRT component in cytokinesis
    Christoph Spitzer, Swen Schellmann, Aneta D. Sabovljević, Mojgan Shahriari, Channa Keshavaiah, Nicole Bechtold, Michel Herzog, Stefan Müller, Franz‐Georg Hanisch, Martin Hülskamp · 2006 · Development
  53. The ubiquitin system, disease, and drug discovery
    Matthew D. Petroski · 2008 · BMC Biochemistry
  54. Circ0008399 Interaction with WTAP Promotes Assembly and Activity of the m6A Methyltransferase Complex and Promotes Cisplatin Resistance in Bladder Cancer
    Wenjie Wei, Jiayin Sun, Hui Zhang, Xingyuan Xiao, Chao Huang, Liang Wang, He Zhong, Yangkai Jiang, Xiaoping Zhang, Guosong Jiang · 2021 · Cancer Research
  55. Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination
    Hideaki Oda, Sushant Kumar, Peter M. Howley · 1999 · Proceedings of the National Academy of Sciences
  56. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses
    Gretchen S. Jimenez, Shireen H Khan, Jayne M. Stommel, Geoffrey M. Wahl · 1999 · Oncogene
  57. Control of p53 ubiquitination and nuclear export by MDM2 and ARF.
    Yanping Zhang, Yue Xiong · 2001 · PubMed
  58. Autoinhibitory Regulation of p73 by ΔNp73 To Modulate Cell Survival and Death through a p73-Specific Target Element within the ΔNp73 Promoter
    Takahito Nakagawa, Masato Takahashi, Toshinori Ozaki, Kenichi Watanabe, Satoru Todo, Hiroyuki Mizuguchi, Takao Hayakawa, Akira Nakagawara · 2002 · Molecular and Cellular Biology
  59. Ribosomal protein S14 unties the MDM2–p53 loop upon ribosomal stress
    Xiang Yu Zhou, Qin Hao, Jingling Liao, Q Zhang, Hua Lu · 2012 · Oncogene
  60. Role of Ubiquitin Ligases and the Proteasome in Oncogenesis: Novel Targets for Anticancer Therapies
    Lindsey N. Micel, John J. Tentler, Peter G. Smith, Gail S. Eckhardt · 2013 · Journal of Clinical Oncology
  61. Tumor suppressor genes
    Kay F. Macleod · 2000 · Current Opinion in Genetics & Development
  62. Sustained oscillations and time delays in gene expression of protein Hes1
    Mogens H. Jensen, Kim Sneppen, Guido Tiana · 2003 · FEBS Letters
  63. p53 Activation by Small Molecules: Application in Oncology
    Lyubomir T. Vassilev · 2005 · Journal of Medicinal Chemistry
  64. MDM2-Regulated Degradation of HIPK2 Prevents p53Ser46 Phosphorylation and DNA Damage-Induced Apoptosis
    Cinzia Rinaldo, Andrea Prodosmo, Francesca Mancini, Stefano Iacovelli, Ada Sacchi, Fabiola Moretti, Silvia Soddu · 2007 · Molecular Cell
  65. DNA damage and oxidant stress activate p53 through differential upstream signaling pathways
    Tao Shi, Daan M. K. van Soest, Paulien E. Polderman, Boudewijn M.T. Burgering, Tobias B. Dansen · 2021 · Free Radical Biology and Medicine
  66. The role of p53-target genes in human cancer
    Takashi Tokino, Yusuke Nakamura · 2000 · Critical Reviews in Oncology/Hematology
  67. Aberrant Expression of Nucleostemin Activates p53 and Induces Cell Cycle Arrest via Inhibition of MDM2
    Mu‐Shui Dai, Xiao‐Xin Sun, Hua Lu · 2008 · Molecular and Cellular Biology
  68. The role of p53 in neuronal cell death
    Richard S. Morrison, Y Kinoshita · 2000 · Cell Death and Differentiation
  69. p21/p53, Cellular Growth Control and Genomic Integrity
    Wafik S. El‐Deiry · 1998 · Current topics in microbiology and immunology
  70. TRIM59 Is Up-regulated in Gastric Tumors, Promoting Ubiquitination and Degradation of p53
    Zhicheng Zhou, Zhongzhong Ji, You Wang, Jian Li, Hui Cao, Helen He Zhu, Wei‐Qiang Gao · 2014 · Gastroenterology
  71. Senescence Regulation by the p53 Protein Family
    Yingjuan Qian, Xinbin Chen · 2012 · Methods in molecular biology
  72. p53 and NF-κB Coregulate Proinflammatory Gene Responses in Human Macrophages
    Julie M. Lowe, Daniel Menéndez, Pierre R. Bushel, Maria Shatz, Erin L. Kirk, Melissa A. Troester, Stavros Garantziotis, Michael B. Fessler, Michael A. Resnick · 2014 · Cancer Research
  73. Genotoxic and non-genotoxic pathways of p53 induction
    Olivier Pluquet, Pierre L. Hainaut · 2001 · Cancer Letters
  74. The Transactivation Domains of the p53 Protein
    Nitin Raj, Laura Donatella Attardi · 2016 · Cold Spring Harbor Perspectives in Medicine
  75. Radioresistant cervical cancer shows upregulation of the NHEJ proteins DNA-PKcs, Ku70 and Ku86
    Catharina Beskow, Jurate Skikuniene, Åsa Holgersson, Bo R Nilsson, Rolf Lewensohn, Lena Kanter, Kristina Viktorsson · 2009 · British Journal of Cancer
  76. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo
    Xirodimas, Dimitris, Saville, Mark K, Edling, Charlotte, Lane, David P, Laín, Sonia · 2001 · Oncogene
  77. p53 from complexity to simplicity: mutant p53 stabilization, gain‐of‐function, and dominant‐negative effect
    Mikhail V. Blagosklonny · 2000 · The FASEB Journal
  78. The relationship between the nucleolus and cancer: Current evidence and emerging paradigms
    Ines Oršolić, Deana Jurada, Nick Pullen, Moshe Oren, Aristides G. Eliopoulos, Siniša Volarević · 2015 · Seminars in Cancer Biology
  79. Inspiration from the mirror: D-amino acid containing peptides in biomedical approaches
    Zhaoqianqi Feng, Bing Xu · 2016 · BioMolecular Concepts
  80. p38 Kinase Regulates Nitric Oxide-induced Apoptosis of Articular Chondrocytes by Accumulating p53 via NFκB-dependent Transcription and Stabilization by Serine 15 Phosphorylation
    Song Ja Kim, Sang‐Gu Hwang, Deug Y. Shin, Shin‐Sung Kang, Jang‐Soo Chun · 2002 · Journal of Biological Chemistry
  81. Frequent Methylation Silencing of p15INK4b(MTS2) and p16INK4a (MTS1) in B-Cell and T-Cell Lymphomas
    Audrey Sylvia Baur, Phil Shaw, Nathalie Hirt‐Burri, Françoise Delacrétaz, Fred T. Bosman, Pascal Chaubert · 1999 · Blood
  82. The role of ubiquitin modification in the regulation of p53
    Hock, Andreas K., Vousden, Karen H. · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  83. Druggability Assessment of Allosteric Proteins by Dynamics Simulations in the Presence of Probe Molecules
    Ahmet Bakan, Neysa Nevins, Ami S. Lakdawala, İvet Bahar · 2012 · Journal of Chemical Theory and Computation
  84. ATM-Mediated Phosphorylations Inhibit Mdmx/Mdm2 Stabilization by HAUSP in Favor of p53 Activation
    Erik Meulmeester, Yaron Pereg, Yosef Shiloh, Aart G. Jochemsen · 2005 · Cell Cycle
  85. Limiting the power of p53 through the ubiquitin proteasome pathway
    Vinod Pant, Guillermina Lozano · 2014 · Genes & Development
  86. Liposarcoma
    Aimee Marie Crago, Mark Andrew Dickson · 2016 · Surgical Oncology Clinics of North America
  87. Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment
    Amit Gupta, Karan Shah, Manisha J. Oza, Tapan Behl · 2018 · Biomedicine & Pharmacotherapy
  88. Human mdm2 Mediates Multiple Mono-ubiquitination of p53 by a Mechanism Requiring Enzyme Isomerization
    Zhihong Lai, Katherine V. Ferry, Melody A. Diamond, Kevin E. Wee, Young B. Kim, Jianhong Ma, Tao Yang, Pamela A. Benfield, Robert A. Copeland, Kurt R. Auger · 2001 · Journal of Biological Chemistry
  89. Redox signalling and transition metals in the control of the p53 pathway
    Catherine Méplan, Marie‐Jeanne Richard, Pierre L. Hainaut · 2000 · Biochemical Pharmacology
  90. The Haemophilus ducreyi Cytolethal Distending Toxin Induces Cell Cycle Arrest and Apoptosis via the DNA Damage Checkpoint Pathways
    Ximena Cortes-Bratti, Christina Karlsson, Teresa Lagergård, Monica Thelestam, Teresa Frisan · 2001 · Journal of Biological Chemistry
  91. Hdmx modulates the outcome of p53 activation in human tumor cells
    Wade, Mark, Wong, Ee Tsin, Tang, Mengjia, Stommel, Jayne M., Wahl, Geoffrey M. · 2006 · Journal of Biological Chemistry
  92. Inactivation of the p53-homologue p73 by the mdm2-oncoprotein
    Dobbelstein, Matthias, Wienzek, Sandra, König, Claudia, Roth, Judith · 1999 · Oncogene
  93. Cbl-b-dependent Coordinated Degradation of the Epidermal Growth Factor Receptor Signaling Complex
    Seth A. Ettenberg, Alessandra Magnifico, Mauricio A. Cuello, Marion M. Nau, Yaffa Rubinstein, Yosef Yarden, Allan M. Weissman, Stan Lipkowitz · 2001 · Journal of Biological Chemistry
  94. The role of DNA damage responses in p53 biology
    Daniel Speidel · 2015 · Archives of Toxicology
  95. Reactive Oxygen Species Induced p53 Activation: DNA Damage, Redox Signaling, or Both?
    Tao Shi, Tobias B. Dansen · 2020 · Antioxidants and Redox Signaling
  96. Life and death decisions by E2F-1
    L A Bell, Kevin M. Ryan · 2003 · Cell Death and Differentiation
  97. Fluctuations in p53 Signaling Allow Escape from Cell-Cycle Arrest
    Reyes, José, Chen, Jia-Yun, Stewart-Ornstein, Jacob, Karhohs, Kyle W., Mock, Caroline S., Lahav, Galit · 2018 · Molecular Cell
  98. Malin Decreases Glycogen Accumulation by Promoting the Degradation of Protein Targeting to Glycogen (PTG)
    Carolyn A. Worby, Matthew S. Gentry, Jack E. Dixon · 2007 · Journal of Biological Chemistry
  99. Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
    Simin Qi, Gang Cheng, Xiangdong Cheng, Zhiyuan Xu, Beihua Xu, Weidong Zhang, Jiang‐Jiang Qin · 2020 · Frontiers in Cell and Developmental Biology
  100. Human Papillomavirus Oncoproteins E6 and E7 Independently Abrogate the Mitotic Spindle Checkpoint
    Jennifer T. Thomas, Laimonis A. Laimins · 1998 · Journal of Virology